A study showed 216 reported cases of suspected TNF inhibitor-induced or -exacerbated psoriasis, which occurred more frequently with infliximab and was most prevalent in the first year of treatment for Crohn's disease and rheumatoid arthritis [228]. Here, TNF is linked to rheumatoid arthritis.